Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $73.2600 (-2.33%) ($73.2600 - $73.2600) on Wed. Jan. 13, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.69% (three month average) | RSI | 46 | Latest Price | $73.2600(-2.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.7% a day on average for past five trading days. | Weekly Trend | EDIT advances 0.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(66%) IWO(61%) IWC(58%) IBUY(57%) IWM(56%) | Factors Impacting EDIT price | EDIT will decline at least -3.845% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-13%) TBT(-7%) UNG(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.845% (StdDev 7.69%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $76.55 | 5 Day Moving Average | $81.14(-9.71%) | 10 Day Moving Average | $78.15(-6.26%) | 20 Day Moving Average | $76.55(-4.3%) | To recent high | -19.4% | To recent low | 164.3% | Market Cap | $4.55b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |